journal article·2010-12

The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions

Hsin-Hui Shen, Jonathan G. Crowston, Florian Huber, Simon Saubern, Keith M. McLean, Patrick G. Hartley

Biomaterials· Volume 31· Issue 36
Publisher page

Abstract

Lyotropic liquid crystalline nanoparticles (cubosomes) have the potential to act as amphiphilic scaffolds for the presentation of lipids and subsequent application in, for example, bioseparations and therapeutic delivery. In this work we have formulated lyotropic liquid crystalline systems based on the synthetic amphiphile 1,2,3-trihydroxy-3,7,11,15-tetramethylhexadecane (phytantriol) and containing the lipid dipalmitoyl phosphatidylserine (DPPS). We have prepared a range of DPPS-containing phytantriol cubosome formulations and characterized them using Small Angle X-ray Scattering and Cryo-transmission electron microscopy. These techniques show that increased DPPS content induces marked changes in lyotropic liquid crystalline phase behaviour, characterized by changes in crystallographic dimensions and increases in vesicle content. Furthermore, in vitro cell culture studies indicate that these changes correlate with lipid/surfactant cellular uptake and cytotoxicity. A model cell membrane based on a surface supported phospholipid bilayer was used to gain insights into cubosome-bilayer interactions using Quartz Crystal Microgravimetry. The data show that mass uptake at the supported bilayer increased with DPPS content. We propose that the cytotoxicity of the DPPS-containing dispersions results from changes in lipid/surfactant phase behaviour and the preferential attachment and fusion of vesicles at the cell membrane.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lipid Membrane Structure and Behavior · Surfactants and Colloidal Systems · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes10.1016/j.chemphyslip.2009.08.003 ↗
2. Layer-by-layer assembly: the new approach for advanced drug release system
3. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin10.1007/s11095-005-8176-x ↗
4. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles10.1016/j.toxlet.2009.04.017 ↗
5. Functionalized micellar systems for cancer targeted drug delivery10.1007/s11095-006-9223-y ↗
6. Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system10.1016/j.jmmm.2005.01.064 ↗
7. Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option?10.1007/s11095-008-9811-0 ↗
8. Effects of hydrostatic pressure on lipid and surfactant phases10.1016/S1359-0294(01)00092-9 ↗
9. Polymorphism of monolayer lipid membrane structures made from unsymmetrical bolaamphiphiles10.1016/j.carres.2005.08.005 ↗
10. Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes10.1016/S0378-5173(00)00466-X ↗
11. Stealth(r) liposomes: from theory to product10.1016/S0169-409X(96)00456-5 ↗
12. Stimuli responsive liquid crystals provide ’on-demand’ drug delivery in vitro and in vivo10.1016/j.jconrel.2009.01.009 ↗
13. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin a: characterization and study of in vitro and in vivo delivery10.1016/j.ejpb.2006.02.003 ↗
14. Dynamic control of nanofluidic channels in protein drug delivery vehicles10.1016/S1773-2247(08)50005-0 ↗
15. Self-assembly of polar food lipids10.1016/j.cis.2006.07.003 ↗
16. Sueess HR, Suess H, Suess HR, inventors; SUEESS H R (SUEE-Individual) SUESS H R (SUES-Non-standard), assignee. Anhydrous, urea-containing dermatological or cosmetic preparations, e.g. Gels or salves, also contain phytantriol plus liquid, branched hydrocarbon, solid polymeric hydrocarbon and possibly other additives patent WO2008025176-A1; EP2056781-A1; IN200901118-P2; CA2661454-A1.
17. Phase behavior of the phytantriol/water system10.1021/la0350812 ↗
18. Phase behavior of phytantriol/water bicontinuous cubic pn3m cubosomes stabilized by laponite disc-like particles10.1016/j.jcis.2009.10.054 ↗
19. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin e acetate and f127 polymer on liquid crystal nanostructure10.1021/la061706v ↗
20. Cubic phases in phosphatidylcholine-cholesterol mixtures: cholesterol as membrane “Fusogen”10.1529/biophysj.106.083766 ↗
21. Australian synchrotron
22. Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity10.1016/j.ejps.2009.07.012 ↗
23. Novel use of silicon nanocrystals and nanodiamonds in biology10.2478/s11696-009-0075-x ↗
24. Rapid colorimetric assay for cellular growth and survivals: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
25. Following the formation of supported lipid bilayers on mica: a study combining afm, qcm-d, and ellipsometry10.1529/biophysj.104.053728 ↗
26. Quartz-crystal microbalance setup for frequency and q-factor measurements in gaseous and liquid environments10.1063/1.1145396 ↗
27. Chlorpromazine associates with phosphatidylserines to cause an increase in the lipid’s own interfacial molecular area – role of the fatty acyl composition10.1016/S0301-4622(01)00152-1 ↗
28. Characterization and potential applications of nanostructured aqueous dispersions10.1016/j.cis.2008.07.007 ↗
29. Crystallography of dispersed liquid crystalline phases studded by cryo-transmission on electron microscopy10.1111/j.1365-2818.2006.01544.x ↗
30. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin e acetate and f127 polymer on liquid crystal nanostructure10.1021/la061706v ↗
31. Phase behavior and aggregate structure in aqueous mixtures of sodium cholate and glycerol monooleate10.1006/jcis.1998.5996 ↗
32. Control of the internal structure of mlo-based isasomes by the addition of diglycerol monooleate and soybean phosphatidylcholine10.1021/la061303v ↗
33. Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents10.1016/j.jcis.2007.07.011 ↗
34. A defective swelling lamellar phase10.1021/la960536r ↗
35. On the swelling of monoolein liquid-crystalline aqueous phases in the presence of distearoylphosphatidylglycerol10.1007/3-540-44941-8_2 ↗
36. Biofunctionalized surfactant mesophases as polyvalent inhibitors of cholera toxin10.1021/bc0700640 ↗
37. Micelles of amphiphilic block copolymers as vehicles for drug delivery
38. Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers10.1016/S0014-5793(99)00208-2 ↗
39. Effect of non-ionic surfactants on the formation of DNA/emulsion complexes and emulsion-mediated gene transfer10.1023/A:1016480421204 ↗
40. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains10.1021/bc049951i ↗
41. Cyclosporine a loaded slns: evaluation of cellular uptake and corneal cytotoxicity10.1016/j.ijpharm.2008.07.028 ↗
42. Nanoparticles from lipid-based liquid crystals: emulsifier influence on morphology and cytotoxicity10.1021/jp9098655 ↗
43. Structure of anionic phospholipid coatings on silica by dissipative quartz crystal microbalance10.1021/la060923t ↗
44. Pathways of lipid vesicle deposition on solid surfaces: a combined qcm-d and afm study10.1016/S0006-3495(03)74722-5 ↗
45. Lipid vesicles and membrane fusion10.1016/S0169-409X(99)00030-7 ↗
46. Membrane-fusion – lipid vesicles as a model system10.1016/0009-3084(86)90068-X ↗
47. Solubilization of hydrophobic guest molecules in the monoolein discontinuous q(l) cubic mesophase and its soft nanoparticles10.1021/la8016084 ↗
48. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction10.1021/la802768q ↗
49. Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma10.1016/j.colsurfb.2004.01.010 ↗
50. 1992
51. Specific targeting with poly(ethylene glycol)-modified liposomes – coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times10.1016/0005-2736(93)90039-3 ↗